Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Cal Gary who wrote (13285)	2/6/2004 3:55:12 PM
From: winzer5	Read Replies (2) \| Respond to of 14101

Looking for a Primer on Short Selling. So they (possibly future underwriters), know/suspect that a financing (percieved as dilutive by the market)is in the works would sell the stock short. The the shares that they get for underwriting is then "delivered" and they pocket the difference between what they borrowed the shares versus the price at delivery (for the scam-bags, hopefully lower)? Is this logic flawed in any way? Does that mean that they could get hammered if the FDA finally comes up with an approval? Or even some brisk sales numbers emerge. Or are they "in the loop" and would pull a Martha with "Dimeclone?" The must use some probility programs before they short? Winzer